Chinese precision oncology firm Burning Rock Biotech reported on Tuesday that its first quarter 2022 revenues were up 27 percent year over year.

Agilent Technologies reported after the close of the market on Tuesday that its fiscal second quarter revenues rose 5 percent year over year.

Castle Biosciences reported after the close of the market on Monday that its first quarter revenues increased 18 percent year over year.

DiaSorin said on Friday that its first quarter revenues rose 34 percent year over year.

On April 28, YHLO (688575. SH) released its annual performance report for 2021. From January 1 to December 31, 2021, the company achieved an operating revenue of 1.178 billion CNY, a year-on-year increase of 17.91%, a net profit of 205 million CNY, a year-on-year decrease of 2.75%.

Thermo Fisher Scientific on Thursday morning reported a 19 percent increase in first quarter revenues, driven by growth in most of its business segments.

MDxHealth reported after the close of the market Wednesday a 21 percent increase in first quarter 2022 sales.

Qiagen on Tuesday afternoon reported strong first quarter revenues that blew by Wall Street estimates, driven by growth in its molecular diagnostics business.

Exact Sciences reported after the close of the market on Tuesday that its first quarter revenues rose 21 percent year over year.

On April 27, Autobio, BSBE, Easy Diagnosis, Medicalsystem, Dian Diagnostics, Hybribio and Kingmed released 2022 Q1 report.